View in EDS HTML Full Text PDF Full Text

Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.

Saved in:
Bibliographic Details
Title: Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
Authors: Varco-Merth B; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Chaunzwa M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Duell DM; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Marenco A; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Goodwin W; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Dannay R; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Shao D; Fred Hutchinson Cancer Research Center, Seattle, Washington State, United States of America., Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Fennessey CM; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Silipino L; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Hull M; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Bosche WJ; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Fast R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Oswald K; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Shoemaker R; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Bochart R; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., MacAllister R; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Labriola CS; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Smedley JV; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Axthelm MK; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Davenport MP; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia., Edlefsen PT; Fred Hutchinson Cancer Research Center, Seattle, Washington State, United States of America., Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Keele BF; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America., Lewin SR; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia., Picker LJ; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America., Okoye AA; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2024 Aug 22; Vol. 20 (8), pp. e1012496. Date of Electronic Publication: 2024 Aug 22 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39173097
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Varco-Merth+B%22">Varco-Merth B</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Chaunzwa+M%22">Chaunzwa M</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Duell+DM%22">Duell DM</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Marenco+A%22">Marenco A</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Goodwin+W%22">Goodwin W</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Dannay+R%22">Dannay R</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Nekorchuk+M%22">Nekorchuk M</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Shao+D%22">Shao D</searchLink>; Fred Hutchinson Cancer Research Center, Seattle, Washington State, United States of America.<br /><searchLink fieldCode="AU" term="%22Busman-Sahay+K%22">Busman-Sahay K</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Fennessey+CM%22">Fennessey CM</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Silipino+L%22">Silipino L</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Hull+M%22">Hull M</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Bosche+WJ%22">Bosche WJ</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Fast+R%22">Fast R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Oswald+K%22">Oswald K</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Shoemaker+R%22">Shoemaker R</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Bochart+R%22">Bochart R</searchLink>; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22MacAllister+R%22">MacAllister R</searchLink>; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Labriola+CS%22">Labriola CS</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Smedley+JV%22">Smedley JV</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Axthelm+MK%22">Axthelm MK</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Davenport+MP%22">Davenport MP</searchLink>; Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Edlefsen+PT%22">Edlefsen PT</searchLink>; Fred Hutchinson Cancer Research Center, Seattle, Washington State, United States of America.<br /><searchLink fieldCode="AU" term="%22Estes+JD%22">Estes JD</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Keele+BF%22">Keele BF</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Lifson+JD%22">Lifson JD</searchLink>; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Lewin+SR%22">Lewin SR</searchLink>; Department of Infectious Diseases, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Victorian Infectious Diseases Service, Royal Melbourne Hospital at The Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Picker+LJ%22">Picker LJ</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.<br /><searchLink fieldCode="AU" term="%22Okoye+AA%22">Okoye AA</searchLink>; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States of America.; Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2024 Aug 22; Vol. 20 (8), pp. e1012496. <i>Date of Electronic Publication: </i>2024 Aug 22 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39173097
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1012496
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1012496
    Titles:
      – TitleFull: Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Varco-Merth B
      – PersonEntity:
          Name:
            NameFull: Chaunzwa M
      – PersonEntity:
          Name:
            NameFull: Duell DM
      – PersonEntity:
          Name:
            NameFull: Marenco A
      – PersonEntity:
          Name:
            NameFull: Goodwin W
      – PersonEntity:
          Name:
            NameFull: Dannay R
      – PersonEntity:
          Name:
            NameFull: Nekorchuk M
      – PersonEntity:
          Name:
            NameFull: Shao D
      – PersonEntity:
          Name:
            NameFull: Busman-Sahay K
      – PersonEntity:
          Name:
            NameFull: Fennessey CM
      – PersonEntity:
          Name:
            NameFull: Silipino L
      – PersonEntity:
          Name:
            NameFull: Hull M
      – PersonEntity:
          Name:
            NameFull: Bosche WJ
      – PersonEntity:
          Name:
            NameFull: Fast R
      – PersonEntity:
          Name:
            NameFull: Oswald K
      – PersonEntity:
          Name:
            NameFull: Shoemaker R
      – PersonEntity:
          Name:
            NameFull: Bochart R
      – PersonEntity:
          Name:
            NameFull: MacAllister R
      – PersonEntity:
          Name:
            NameFull: Labriola CS
      – PersonEntity:
          Name:
            NameFull: Smedley JV
      – PersonEntity:
          Name:
            NameFull: Axthelm MK
      – PersonEntity:
          Name:
            NameFull: Davenport MP
      – PersonEntity:
          Name:
            NameFull: Edlefsen PT
      – PersonEntity:
          Name:
            NameFull: Estes JD
      – PersonEntity:
          Name:
            NameFull: Keele BF
      – PersonEntity:
          Name:
            NameFull: Lifson JD
      – PersonEntity:
          Name:
            NameFull: Lewin SR
      – PersonEntity:
          Name:
            NameFull: Picker LJ
      – PersonEntity:
          Name:
            NameFull: Okoye AA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 08
              Text: 2024 Aug 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1